Eva Rivero‐Buceta

Amino modified metal-organic frameworks as pH-responsive nanoplatforms for safe delivery of camptothecin

Alejandro Cabrera-García, Elisa Checa-Chavarria, Eva Rivero‐Buceta et al. · Journal of Colloid and Interface Science · 2019 · 58 citations · Full text

Nanomedicine, Engineering, Organic Chemistry +8

Protein Corona over Mesoporous Silica Nanoparticles: Influence of the Pore Diameter on Competitive Adsorption and Application to Prostate Cancer Diagnostics

Carla Vidaurre-Agut, Eva Rivero‐Buceta, Eva Romaní-Cubells et al. · ACS Omega · 2019 · 54 citations · Full text

Nanoparticles, Protein Corona, Engineering +21

PSMA-Targeted Mesoporous Silica Nanoparticles for Selective Intracellular Delivery of Docetaxel in Prostate Cancer Cells

Eva Rivero‐Buceta, Carla Vidaurre-Agut, C.D. Vera Donoso et al. · ACS Omega · 2019 · 50 citations · Full text

Nanoparticles, Engineering, Prostate Cancer Cells +18

Linear and branched alkyl-esters and amides of gallic acid and other (mono-, di- and tri-) hydroxy benzoyl derivatives as promising anti-HCV inhibitors

Eva Rivero‐Buceta, Paula Carrero, Elisa G. Doyagüez et al. · European Journal of Medicinal Chemistry · 2015 · 39 citations · Full text

Medicinal Chemistry, Pharmaceutical Chemistry, Derivatives +10

Tryptophan dendrimers that inhibit HIV replication, prevent virus entry and bind to the HIV envelope glycoproteins gp120 and gp41

Eva Rivero‐Buceta, Elisa G. Doyagüez, Ignacio Colomer et al. · European Journal of Medicinal Chemistry · 2015 · 35 citations

Hiv Envelope, Antiviral Compound, Biochemistry +12